全文获取类型
收费全文 | 814篇 |
免费 | 107篇 |
专业分类
儿科学 | 21篇 |
妇产科学 | 12篇 |
基础医学 | 103篇 |
口腔科学 | 5篇 |
临床医学 | 80篇 |
内科学 | 263篇 |
皮肤病学 | 31篇 |
神经病学 | 17篇 |
特种医学 | 23篇 |
外科学 | 60篇 |
综合类 | 31篇 |
一般理论 | 3篇 |
预防医学 | 113篇 |
眼科学 | 19篇 |
药学 | 50篇 |
肿瘤学 | 90篇 |
出版年
2021年 | 7篇 |
2019年 | 6篇 |
2018年 | 8篇 |
2017年 | 8篇 |
2016年 | 13篇 |
2015年 | 15篇 |
2014年 | 12篇 |
2013年 | 19篇 |
2012年 | 30篇 |
2011年 | 32篇 |
2010年 | 32篇 |
2009年 | 27篇 |
2008年 | 45篇 |
2007年 | 48篇 |
2006年 | 55篇 |
2005年 | 55篇 |
2004年 | 41篇 |
2003年 | 35篇 |
2002年 | 49篇 |
2001年 | 29篇 |
2000年 | 32篇 |
1999年 | 31篇 |
1998年 | 23篇 |
1997年 | 18篇 |
1996年 | 26篇 |
1995年 | 12篇 |
1994年 | 10篇 |
1993年 | 10篇 |
1992年 | 18篇 |
1991年 | 14篇 |
1990年 | 18篇 |
1989年 | 11篇 |
1988年 | 7篇 |
1987年 | 14篇 |
1986年 | 5篇 |
1983年 | 4篇 |
1980年 | 6篇 |
1979年 | 6篇 |
1978年 | 6篇 |
1977年 | 4篇 |
1975年 | 4篇 |
1973年 | 3篇 |
1972年 | 4篇 |
1971年 | 4篇 |
1970年 | 7篇 |
1969年 | 5篇 |
1968年 | 5篇 |
1967年 | 5篇 |
1959年 | 3篇 |
1954年 | 5篇 |
排序方式: 共有921条查询结果,搜索用时 15 毫秒
61.
Gilliland FD Joste N Stauber PM Hunt WC Rosenberg R Redlich G Key CR 《Journal of the National Cancer Institute》2000,92(9):743-749
BACKGROUND: Interval breast cancer is defined as a cancer that is detected within 12 months after a negative mammogram. The failure of mammography to detect breast cancer depends on testing procedures, radiologist interpretation, patient characteristics, and tumor properties. Although errors by radiologists explain some interval cancers, another explanation is that the tumor is rapidly growing and was too small to be detected on the last mammogram. To determine whether markers of tumor growth rate are associated with risk of an interval cancer, we conducted a population-based study with the use of data collected statewide by the New Mexico Mammography Project. METHODS: Among women who received a mammographic examination from 1991 throughout 1993, we ascertained records of all patients with breast cancer diagnosed within 12 months of a negative screening mammographic examination (interval cancers) and corresponding tumor samples, when available. We selected an age- and ethnicity-matched comparison group of control patients with screen-detected breast cancers diagnosed during the same period. In tumor samples, p53, bcl-2, and Ki-67 were examined immunologically and the apoptotic index was assessed histologically. We used logistic regression to determine whether interval cancers were associated with selected demographic, radiologic, and biologic characteristics. RESULTS: It is more likely that mammography did not detect tumors with a high proportion of proliferating cells (>20%) than tumors with a low proportion of proliferating cells (<5%) (odds ratio [OR] = 4.09; 95% confidence interval [CI] = 1.14-14.65). The OR for mammographic failure was 2.96 (95% CI = 1.07-8.20) among cancers that expressed p53 compared with cancers that did not. Interval cancers also had fewer apoptotic cells. Approximately 75% of interval cancers appear to have tumors with 5% proliferating cells or more. Younger women had a higher proportion of rapidly proliferating and aggressive cancers. CONCLUSION: Rapidly growing and aggressive tumors account for a substantial proportion of mammographic failure to detect breast cancer, especially among younger women, who have a high proportion of aggressive cancers. 相似文献
62.
E L Gilliland 《British medical journal》1987,294(6581):1228-1229
63.
64.
BACKGROUND: Good asthma control requires optimal medical treatment in conjunction with appropriate self-management. In the West, the effectiveness of patient education on improving self-management has been well documented. However, data amongst Asian populations are lacking. We performed a pilot study to evaluate the efficacy of a hospital based education programme aimed at improving self-management skills and reducing morbidity in a Chinese population with low socioeconomic status and education level. METHODS: Our asthma education programme was a low-cost programme conducted in essence by specialist respiratory nurses. Patients attending our asthma clinic were instructed during a two-hour educational session on the pathophysiology of asthma, its potential triggers, the appropriate use of medications including proper inhaler techniques, and the self-management of their disease. These instructions were reinforced by video sessions at subsequent outpatient clinic attendance when patients' inhaler and peak flow techniques were checked by the same nurses and their self-management plan re-examined by the attending physicians. Asthma knowledge, inhaler technique, FEV1 and peak expiratory flow (PEF), and patients' self-rating of their asthma were determined at baseline, 6 months and 1 year after the intervention. Morbidity was assessed by the numbers of hospitalizations, unscheduled visits to family physicians and accident and emergency department attendance, courses of oral steroid used and days off work or school at baseline and 1 year. RESULTS: Two hundred and thirty patients were recruited for the study, 83% completing the entire assessment period. The group demonstrated significant improvements in lung function: the mean FEV1 +/- SD increased from 63.6 +/- 20.6% of predicted values at baseline to 68.5 +/- 22.3% at 6 months and 68.6 +/- 22.8% at 1 year (P < 0.05), and the mean PEF +/- SD increased from 64.6 +/- 23.0% of predicted values at baseline to 75.4 +/- 27.0% at 6 months and 76.8 +/- 24.5% at 1 year(P < 0.001). There were also significant improvements in inhaler technique (P < 0.01), asthma knowledge (P < 0.001), patients' self-rating of their asthma (P < 0.05), and reductions in the numbers of hospitalizations (P < 0.01), visits to family physicians (P < 0.001) and accident and emergency department attendance (P < 0.001) during the study period. Patients with moderate to severe asthma as defined by an FEV1 of < 80% of predicted values were most likely to benefit from the programme. CONCLUSIONS: We conclude that patient education is likely to be an essential component in the holistic approach to the management of asthma even amongst Asian populations of low socioeconomic status and education level. Further studies using randomised controlled trials are necessary to consolidate our findings. 相似文献
65.
LI-KAI LO M.D. TSENG-FANG TSAI M.D. † YU-FU CHEN M.D. CHI-MING HUNG M.D. WANG-CHENG KO M.D. 《Pediatric dermatology》2009,26(1):111-112
Abstract: Connective tissue nevi of collagen type are now classified in four major subtypes. In addition to the clinicopathological features of papulolinear collagenoma, which is considered as a variant of isolated collagen harmatoma, the case we present has a unique arborizing pattern. 相似文献
66.
Stable expression of small interfering RNA sensitizes TEL-PDGFbetaR to inhibition with imatinib or rapamycin 总被引:5,自引:0,他引:5
Chen J Wall NR Kocher K Duclos N Fabbro D Neuberg D Griffin JD Shi Y Gilliland DG 《The Journal of clinical investigation》2004,113(12):1784-1791
Small molecule inhibitors, such as imatinib, are effective therapies for tyrosine kinase fusions BCR-ABL-TEL-PDGFbetaR-mediated human leukemias, but resistance may develop. The unique fusion junctions of these molecules are attractive candidates for molecularly targeted therapeutic intervention using RNA interference (RNAi), which is mediated by small interfering RNA (siRNA). We developed a retroviral system for stable expression of siRNA directed to the unique fusion junction sequence of TEL-PDGFbetaR in transformed hematopoietic cells. Stable expression of the siRNA resulted in approximately 90% inhibition of TEL-PDGFbetaR expression and its downstream effectors, including PI3K and mammalian target of rapamycin (mTOR). Expression of TEL-PDGFbetaR-specific siRNA (TPsiRNA) significantly attenuated the proliferation of TEL-PDGFbetaR-transformed Ba/F3 cells or disease latency and penetrance in mice induced by intravenous injection of these Ba/F3 cells. Although a 90% reduction in TEL-PDGFbetaR expression was insufficient to induce cell death, stable siRNA expression sensitized transformed cells to the PDGFbetaR inhibitor imatinib or to the mTOR inhibitor rapamycin. TPsiRNA also inhibited an imatinib-resistant TEL-PDGFbetaR mutant, and the inhibition was enhanced by siRNA in combination with PKC412, another PDGFbetaR inhibitor. Although siRNA delivery in vivo is a challenging problem, stable expression of siRNA, which targets oncogenic fusion genes, may potentiate the effects of conventional therapy for hematologic malignancies. 相似文献
67.
The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis 总被引:3,自引:0,他引:3 下载免费PDF全文
68.
Parul H. Kothari Weiliang Qiu Damien C. Croteau-Chonka Fernando D. Martinez Andrew H. Liu Robert F. Lemanske Carole Ober Jerry A. Krishnan Dan L. Nicolae Kathleen C. Barnes Stephanie J. London Albino Barraza-Villarreal Steven R. White Edward T. Naureckas Joshua Millstein W. James Gauderman Frank D. Gilliland Vincent J. Carey Benjamin A. Raby 《The Journal of allergy and clinical immunology》2018,141(6):2282-2286.e6
69.
70.
Pardanani A Ketterling RP Brockman SR Flynn HC Paternoster SF Shearer BM Reeder TL Li CY Cross NC Cools J Gilliland DG Dewald GW Tefferi A 《Blood》2003,102(9):3093-3096